{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:30Z","timestamp":1792788090247,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH","id":[{"id":"https:\/\/ror.org\/00yq55g44","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) requiring invasive mechanical ventilation (IMV) are associated with high mortality and long-term disability. Extracorporeal CO\u2082 removal (ECCO\u2082R) using modern high-capacity devices may facilitate early endotracheal extubation and reduce IMV-related complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To evaluate whether ECCO\n                      <jats:sub>2<\/jats:sub>\n                      R-facilitated early extubation improves clinical outcomes compared with standard IMV in patients with severe AE-COPD requiring IMV.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Adults with acute hypercapnic respiratory failure due to AE-COPD requiring IMV who failed or were ineligible for extubation within 24\u2009hours of intubation were randomized to ECCO\n                      <jats:sub>2<\/jats:sub>\n                      R or no ECCO\n                      <jats:sub>2<\/jats:sub>\n                      R. The primary endpoint was a composite of death or severe disability at day 60.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      18 patients were randomized before the trial was terminated early by the sponsor for financial reasons (planned enrollment: 192). The primary composite endpoint occurred in 0\/8 ECCO\n                      <jats:sub>2<\/jats:sub>\n                      R-treated patients versus 3\/9 evaluable IMV-treated patients (33%; risk difference \u221233%; 95% CI \u221265% to 6%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.21). IMV duration was shorter in the ECCO\n                      <jats:sub>2<\/jats:sub>\n                      R group (7.1\u2009\u00b1\u20092.0 vs. 24.3\u2009\u00b1\u200921.4\u2009days; median 7.0 vs. 16.0\u2009days; mean difference \u221217.2\u2009days;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043), yielding, in a post hoc exploratory analysis, more overall device-free days at day 29 (17\u2009\u00b1\u20094 device-support-free days compared with 8\u2009\u00b1\u20097\u2009days in the IMV group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011)). Ventilator-associated pneumonia occurred in 0 versus 3 patients (37.5%), respectively. Sedation was discontinued earlier in the ECCO\u2082R group. Severe bleeding occurred in one ECCO\u2082R-treated patient (12.5%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In this prematurely terminated trial, ECCO\u2082R-facilitated early extubation using a device with a capacity to eliminate more than 50% of the average CO\n                      <jats:sub>2<\/jats:sub>\n                      production, was associated with a shorter duration of invasive mechanical ventilation. Numerical trends favored ECCO\n                      <jats:sub>2<\/jats:sub>\n                      R across several secondary outcomes, although interpretation is limited by premature termination and the very small sample size. Adequately powered multicenter trials are warranted.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-026-06300-6","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:06:02Z","timestamp":1788455162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extracorporeal CO2 elimination for acute exacerbation of severe COPD requiring invasive mechanical ventilation: a randomized controlled trial (the X-COPD trial)"],"prefix":"10.1186","volume":"30","author":[{"given":"Christian","family":"Karagiannidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Riera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Blanco-Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Strassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Merten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Staudinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Windisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Brochard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Slutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"6300_CR1","doi-asserted-by":"publisher","first-page":"100954","DOI":"10.1016\/j.lanepe.2024.100954","volume":"42","author":"C Karagiannidis","year":"2024","unstructured":"Karagiannidis C, Krause F, Bentlage C, Wolff J, Bein T, Windisch W, et al. In-hospital mortality, comorbidities, and costs of one million mechanically ventilated patients in Germany: a nationwide observational study before, during, and after the COVID-19 pandemic. Lancet Reg Health Eur. 2024;42:100954. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100954.","journal-title":"Lancet Reg Health Eur"},{"issue":"2","key":"6300_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1164\/rccm.201106-1094OC","volume":"185","author":"D Chandra","year":"2012","unstructured":"Chandra D, Stamm JA, Taylor B, Ramos RM, Satterwhite L, Krishnan JA, et al. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. Am J Respir Crit Care Med. 2012;185(2):152\u201359.","journal-title":"Am J Respir Crit Care Med"},{"issue":"18","key":"6300_CR3","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1001\/jama.284.18.2361","volume":"284","author":"E Girou","year":"2000","unstructured":"Girou E, Schortgen F, Delclaux C, Brun-Buisson C, Blot F, Lefort Y, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA. 2000;284(18):2361\u201367.","journal-title":"JAMA"},{"issue":"20","key":"6300_CR4","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1001\/jama.2024.15815","volume":"332","author":"Z Luo","year":"2024","unstructured":"Luo Z, Li Y, Li W, Li Y, Nie Q, Shi Y, et al. Effect of high-intensity vs low-intensity noninvasive positive pressure ventilation on the need for endotracheal intubation in patients with an acute exacerbation of chronic obstructive pulmonary disease: the HAPPEN randomized clinical trial. JAMA. 2024;332(20):1709\u201322. https:\/\/doi.org\/10.1001\/jama.2024.15815.","journal-title":"JAMA"},{"issue":"1","key":"6300_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13613-018-0384-8","volume":"8","author":"SE Huttmann","year":"2018","unstructured":"Huttmann SE, Magnet FS, Karagiannidis C, Storre JH, Windisch W. Quality of life and life satisfaction are severely impaired in patients with long-term invasive ventilation following ICU treatment and unsuccessful weaning. Ann Intensive Care. 2018;8(1):38. https:\/\/doi.org\/10.1186\/s13613-018-0384-8.","journal-title":"Ann Intensive Care"},{"issue":"5","key":"6300_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00134-019-05567-4","volume":"45","author":"A Combes","year":"2019","unstructured":"Combes A, Fanelli V, Pham T, Ranieri VM. European society of intensive Care medicine trials G, the \u201cstrategy of ultra-protective lung ventilation with extracorporeal CORfN-OmtsAi. Feasibility and safety of extracorporeal CO(2) removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Med. 2019;45(5):592\u2013600. https:\/\/doi.org\/10.1007\/s00134-019-05567-4.","journal-title":"Intensive Care Med"},{"key":"6300_CR7","doi-asserted-by":"publisher","unstructured":"Karagiannidis C, Kampe KA, Sipmann FS, Larsson A, Hedenstierna G, Windisch W, et al. Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations. Crit Care. 2014;18(3):R124. https:\/\/doi.org\/10.1186\/cc13928.","DOI":"10.1186\/cc13928"},{"issue":"1","key":"6300_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jcm14010012","volume":"14","author":"T Lamas","year":"2024","unstructured":"Lamas T, Fernandes SM, Vasques F, Karagiannidis C, Camporota L, Barrett N. Recent advances and future directions in extracorporeal carbon dioxide removal. J Clin Med. 2024;14(1):12. https:\/\/doi.org\/10.3390\/jcm14010012.","journal-title":"J Clin Med"},{"issue":"9","key":"6300_CR9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00134-019-05708-9","volume":"45","author":"EC Goligher","year":"2019","unstructured":"Goligher EC, Combes A, Brodie D, Ferguson ND, Pesenti AM, Ranieri VM, et al. Determinants of the effect of extracorporeal carbon dioxide removal in the SUPERNOVA trial: implications for trial design. Intensive Care Med. 2019;45(9):1219\u201330. https:\/\/doi.org\/10.1007\/s00134-019-05708-9.","journal-title":"Intensive Care Med"},{"issue":"1","key":"6300_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40635-019-0244-3","volume":"7","author":"S Strassmann","year":"2019","unstructured":"Strassmann S, Merten M, Schafer S, de Moll J, Brodie D, Larsson A, et al. Impact of sweep gas flow on extracorporeal CO(2) removal (ECCO(2)R). Intensive Care Med Exp. 2019;7(1):17.","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"6300_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40635-017-0147-0","volume":"5","author":"C Karagiannidis","year":"2017","unstructured":"Karagiannidis C, Strassmann S, Brodie D, Ritter P, Larsson A, Borchardt R, et al. Impact of membrane lung surface area and blood flow on extracorporeal CO(2) removal during severe respiratory acidosis. Intensive Care Med Exp. 2017;5(1):34.","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"6300_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/CCM.0000000000000607","volume":"43","author":"L Del Sorbo","year":"2015","unstructured":"Del Sorbo L, Pisani L, Filippini C, Fanelli V, Fasano L, Terragni P, et al. Extracorporeal Co2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Crit Care Med. 2015;43(1):120\u201327.","journal-title":"Crit Care Med"},{"issue":"1","key":"6300_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13054-019-2404-y","volume":"23","author":"C Karagiannidis","year":"2019","unstructured":"Karagiannidis C, Strassmann S, Schwarz S, Merten M, Fan E, Beck J, et al. Control of respiratory drive by extracorporeal CO2 removal in acute exacerbation of COPD breathing on non-invasive NAVA. Crit Care. 2019;23(1):135. https:\/\/doi.org\/10.1186\/s13054-019-2404-y.","journal-title":"Crit Care"},{"issue":"9","key":"6300_CR14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00134-016-4452-y","volume":"42","author":"S Braune","year":"2016","unstructured":"Braune S, Sieweke A, Brettner F, Staudinger T, Joannidis M, Verbrugge S, et al. The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case\u2013control study. Intensive Care Med. 2016;42(9):1437\u201344. https:\/\/doi.org\/10.1007\/s00134-016-4452-y.","journal-title":"Intensive Care Med"},{"issue":"8","key":"6300_CR15","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00134-015-3917-8","volume":"41","author":"C Karagiannidis","year":"2015","unstructured":"Karagiannidis C, Strassmann S, Philipp A, Muller T, Windisch W. Veno-venous extracorporeal CO2 removal improves pulmonary hypertension in acute exacerbation of severe COPD. Intensive Care Med. 2015;41(8):1509\u201310. https:\/\/doi.org\/10.1007\/s00134-015-3917-8.","journal-title":"Intensive Care Med"},{"issue":"4","key":"6300_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1513\/AnnalsATS.201301-021OC","volume":"10","author":"DC Abrams","year":"2013","unstructured":"Abrams DC, Brenner K, Burkart KM, Agerstrand CL, Thomashow BM, Bacchetta M, et al. Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10(4):307\u201314.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"6300_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1164\/rccm.202311-2060OC","volume":"209","author":"A Duggal","year":"2024","unstructured":"Duggal A, Conrad SA, Barrett NA, Saad M, Cheema T, Pannu S, et al. Extracorporeal carbon dioxide removal to avoid invasive ventilation during exacerbations of chronic obstructive pulmonary disease: VENT-AVOID trial - a randomized clinical trial. Am J Respir Crit Care Med. 2024;209(5):529\u201342.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"6300_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jama.2021.13374","volume":"326","author":"JJ McNamee","year":"2021","unstructured":"McNamee JJ, Gillies MA, Barrett NA, Perkins GD, Tunnicliffe W, Young D, et al. Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard Care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: the REST randomized clinical trial. JAMA. 2021;326(11):1013\u201323. https:\/\/doi.org\/10.1001\/jama.2021.13374.","journal-title":"JAMA"},{"issue":"5","key":"6300_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/MAT.0000000000000544","volume":"63","author":"J Kalbhenn","year":"2017","unstructured":"Kalbhenn J, Neuffer N, Zieger B, Schmutz A. Is extracorporeal CO2 removal really \u201csafe\u201d and \u201cless\u201d invasive? Observation of blood injury and coagulation impairment during ECCO2R. Asaio J. 2017;63(5):666\u201371. https:\/\/doi.org\/10.1097\/MAT.0000000000000544.","journal-title":"Asaio J"},{"issue":"5","key":"6300_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00134-012-2787-6","volume":"39","author":"T Bein","year":"2013","unstructured":"Bein T, Weber-Carstens S, Goldmann A, Muller T, Staudinger T, Brederlau J, et al. Lower tidal volume strategy (approximately 3 ml\/kg) combined with extracorporeal CO2 removal versus \u2018conventional\u2019 protective ventilation (6 ml\/kg) in severe ARDS: the prospective randomized xtravent-study. Intensive Care Med. 2013;39(5):847\u201356.","journal-title":"Intensive Care Med"},{"key":"6300_CR21","doi-asserted-by":"publisher","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):e61\u2013111. https:\/\/doi.org\/10.1093\/cid\/ciw353.","DOI":"10.1093\/cid\/ciw353"},{"issue":"5","key":"6300_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1183\/09031936.00010206","volume":"29","author":"JM Boles","year":"2007","unstructured":"Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, et al. Weaning from Mechanical ventilation. Eur Respir J. 2007;29(5):1033\u201356. https:\/\/doi.org\/10.1183\/09031936.00010206.","journal-title":"Eur Respir J"},{"key":"6300_CR23","doi-asserted-by":"publisher","unstructured":"Davidson AC, Banham S, Elliott M, Kennedy D, Gelder C, Glossop A, et al. BTS\/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax. 2016;71(Suppl 2):ii1\u201335. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-208209.","DOI":"10.1136\/thoraxjnl-2015-208209"},{"issue":"2","key":"6300_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1513\/AnnalsATS.202006-722OC","volume":"19","author":"N Putcha","year":"2022","unstructured":"Putcha N, Anzueto AR, Calverley PMA, Celli BR, Tashkin DP, Metzdorf N, et al. Mortality and exacerbation risk by Body Mass index in patients with COPD in TIOSPIR and UPLIFT. Ann Am Thorac Soc. 2022;19(2):204\u201313. https:\/\/doi.org\/10.1513\/AnnalsATS.202006-722OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"13","key":"6300_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1056\/NEJM199509283331301","volume":"333","author":"L Brochard","year":"1995","unstructured":"Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333(13):817\u201322. https:\/\/doi.org\/10.1056\/NEJM199509283331301.","journal-title":"N Engl J Med"},{"issue":"22","key":"6300_CR26","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1001\/jama.290.22.2985","volume":"290","author":"E Girou","year":"2003","unstructured":"Girou E, Brun-Buisson C, Taille S, Lemaire F, Brochard L. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA. 2003;290(22):2985\u201391.","journal-title":"JAMA"},{"issue":"12","key":"6300_CR27","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1007\/s00134-010-1982-6","volume":"36","author":"C Karagiannidis","year":"2010","unstructured":"Karagiannidis C, Lubnow M, Philipp A, Riegger GAJ, Schmid C, Pfeifer M, et al. Autoregulation of ventilation with neurally adjusted ventilatory assist on extracorporeal lung support. Intensive Care Med. 2010;36(12):2038\u201344. https:\/\/doi.org\/10.1007\/s00134-010-1982-6.","journal-title":"Intensive Care Med"},{"issue":"7","key":"6300_CR28","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1164\/rccm.202309-1628LE","volume":"209","author":"B Barbic","year":"2024","unstructured":"Barbic B, Bianchi C, Madotto F, Sklar MC, Karagiannidis C, Fan E, et al. The failure of extracorporeal carbon dioxide removal May Be a failure of technology. Am J Respir Crit Care Med. 2024;209(7):884\u201387. https:\/\/doi.org\/10.1164\/rccm.202309-1628LE.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"6300_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ajrccm\/aamaf117","volume":"212","author":"AS Slutsky","year":"2026","unstructured":"Slutsky AS, Brodie D. The (broken) promise of extracorporeal carbon dioxide removal-failure or future? Am J Respir Crit Care Med. 2026;212(3):414\u201319.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"6300_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1164\/rccm.202401-0176ED","volume":"209","author":"L Piquilloud","year":"2024","unstructured":"Piquilloud L. Extracorporeal carbon dioxide removal in chronic obstructive pulmonary disease: it depends on the Objective! Am J Respir Crit Care Med. 2024;209(5):472\u201373. https:\/\/doi.org\/10.1164\/rccm.202401-0176ED.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"6300_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13054-024-05121-9","volume":"28","author":"C Blum","year":"2024","unstructured":"Blum C, Landoll M, Strassmann SE, Steinseifer U, Neidlin M, Karagiannidis C. Blood trauma in veno-venous extracorporeal membrane oxygenation: low pump pressures and low circuit resistance matter. Crit Care. 2024;28(1):330. https:\/\/doi.org\/10.1186\/s13054-024-05121-9.","journal-title":"Crit Care"},{"issue":"1","key":"6300_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12967-020-02599-z","volume":"19","author":"M Schops","year":"2021","unstructured":"Schops M, Gross-Hardt SH, Schmitz-Rode T, Steinseifer U, Brodie D, Clauser JC, et al. Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump. J Transl Med. 2021;19(1):2. https:\/\/doi.org\/10.1186\/s12967-020-02599-z.","journal-title":"J Transl Med"},{"issue":"1","key":"6300_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s13054-019-2622-3","volume":"23","author":"S Gross-Hardt","year":"2019","unstructured":"Gross-Hardt S, Hesselmann F, Arens J, Steinseifer U, Vercaemst L, Windisch W, et al. Low-flow assessment of current ECMO\/ECCO2R rotary blood pumps and the potential effect on hemocompatibility. Crit Care. 2019;23(1):348. https:\/\/doi.org\/10.1186\/s13054-019-2622-3.","journal-title":"Crit Care"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06300-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06300-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06300-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:30:55Z","timestamp":1789983055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06300-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6300"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06300-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in compliance with the international standard ISO 14155 (Clinical investigation of medical devices for human subjects - Good clinical practice), the European Medical Device Directive, the Declaration of Helsinki (with amendments) and any other applicable legal and regulatory requirements and approved by the ethical committee Z-303\/2020 (University Witten\/Herdecke). Clinical Trials No: NCT03584295, Eudamed-No: CIV-20-12-035287. Written informed consent was obtained from all capable patients before they were screened for study eligibility. Many of the patients approached for participation had limited decision-making abilities as a result of their critical illness. If a patient was incapable of giving informed consent, consent for study inclusion was sought from authorized representatives according to applicable laws and regulations.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Antonio Pesenti (EMERGENCY ONG ETS, Milan, Italy antonio.pesenti@unimi.it., Universit\u00e0 degli Studi di Milano, Milan, Italy), Mike Lars Broman (ECMO Center Karolinska, Department of Pediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden), Niall Ferguson (Toronto General Hospital, Head of Critical Care, UHN & Mount Sinai, Niall.ferguson@uhn.ca) and Christophe Guervilly (Service de M\u00e9decine Intensive-R\u00e9animation, H\u00f4pital Nord, Assistance Publique-H\u00f4pitaux de Marseille, Marseille, France, christophe.guervilly@ap-hm.fr).","order":2,"name":"Ethics","label":"List of collaborators","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Please see the ICMJE disclosure forms, which have been provided as supplementary material. Concerning this work, C.K. received advisory fees from Fresenius Medical Care Germany GmbH and Bayer Germany, lecture fees from Getinge, Germany. C.K. is the speaker of the German register of ICUs. J.R. and T.S. received lecture fees from Getinge, Germany. P.B.S., St.St and M.M. report no conflicts of interest. A.S.S. has been or is a consultant for Draeger, Krypton Medical, Predicate AI Labs, Signal1, Stimit, and Vantive; he is co-chair of the Scientific Committee and is on the Board of the International ECMO Network (ECMONet). D.B. previously consulted for LivaNova; has been on the medical advisory boards for Medtronic, Inspira, HBOX Therapies, and Vantive; is the President of the Extracorporeal Life Support Organization and Chair of the Board of ECMONet; and writes for UpToDate. W.W. reported grants from L\u00f6wenstein Medical, Germany, Philips\/Respironics, USA and GCI, Great Britain and Consulting fees from Philips\/Respironics, USA. W.W. was Past President of the German Respiratory Society and serves as Co-chair of the German Airway League. LB received unrestricted research grants or equipment from Medtronic, Draeger, Stimit, Vitalair, Fisher Paykel, Sentec and fees from Stimit and Fisher Paykel.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"458"}}